Back to Search
KAPIL BHALLA, MD
MD
Hematology & Oncology Physician
NPI: 1609806819IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
45052(TX)R5245(TX)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OTHER
Class of 1975
Research & Publications (20)
Quantitative determination of gibberellins by high performance liquid chromatography from various gibberellins producing Fusarium strains.
PMID 19626451·Environ Monit Assess·2010
8-other
Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin Lymphoma.
PMID 19663825·Br J Haematol·2009
3-trial
Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells.
PMID 19638619·Blood·2009
8-other
Co-treatment with heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin (DMAG) and vorinostat: a highly active combination against human mantle cell lymphoma (MCL) cells.
PMID 19440035·Cancer Biol Ther·2009
8-other
Investigational drugs targeting FLT3 for leukemia.
PMID 19671038·Expert Opin Investig Drugs·2009
6-review
Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944).
PMID 18306034·Breast Cancer Res Treat·2009
3-trial
Adverse health outcomes of road traffic injuries in Iran after rapid motorization.
PMID 19400607·Arch Iran Med·2009
6-review
p53 acetylation is crucial for its transcription-independent proapoptotic functions.
PMID 19265193·J Biol Chem·2009
8-other
Fire-related deaths in India in 2001: a retrospective analysis of data.
PMID 19250664·Lancet·2009
8-other
Data sources for improving estimates of the global burden of injuries: call for contributors.
PMID 19166263·PLoS Med·2009
8-other
Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanism.
PMID 19074726·Blood·2009
7-preclinical
Panobinostat treatment depletes EZH2 and DNMT1 levels and enhances decitabine mediated de-repression of JunB and loss of survival of human acute leukemia cells.
PMID 19279403·Cancer Biol Ther·2009
8-other
The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance.
PMID 19011628·Nat Immunol·2009
7-preclinical
Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V.
PMID 18986703·Leuk Res·2009
5-case
Building national estimates of the burden of road traffic injuries in developing countries from all available data sources: Iran.
PMID 19494093·Inj Prev·2009
8-other
Alterations in CDH15 and KIRREL3 in patients with mild to severe intellectual disability.
PMID 19012874·Am J Hum Genet·2008
8-other
Cotreatment with vorinostat enhances activity of MK-0457 (VX-680) against acute and chronic myelogenous leukemia cells.
PMID 18829489·Clin Cancer Res·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1609806819
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 51
- Publications
- 20
Are you this provider?
Claim Your Profile